The public is notified by the US FDA that the dose limitation for simvastatin has been revised

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2012年 / 1383卷 / 1期

关键词：

Public Health; Simvastatin; Dose Reduction; Amiodarone; Dose Limitation;

D O I：

10.2165/00128415-201213830-00009

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：4 / 4

相关论文

共 12 条

[1] Topiramate labelling has been revised in the US
Reactions Weekly, 2000, 807 (1) : 4 - 4
[2] The FDA and Lilly have notified healthcare professionals that the prescribing information for Zyprexa [olanzapine] has been changed
Reactions Weekly, 2010, 1287 (1) : 3 - 3
[3] The US Public Citizen group has demanded that the US FDA remove alosetron [`Lotronex']
Reactions Weekly, 2000, 829 (1) : 2 - 2
[4] The US FDA has been criticised for its handling of the investigation into the contaminated heparin crisis.*
Reactions Weekly, 2010, 1329 (1) : 4 - 4
[5] The US FDA has informed healthcare professionals that Baxter has revised the Warnings section of the labelling for heparin sodium injection
Reactions Weekly, 2006, 1132 (1) : 2 - 2
[6] A safety alert for Intestinomicina, an antidiarrhoeal product containing chloramphenicol, has been issued by the US FDA.
Reactions Weekly, 2012, 1421 (1) : 3 - 3
[7] The US FDA has announced that topiramate [Topamax] use in pregnant women has been linked to an increased chance of oral cleft
Reactions Weekly, 2011, 1342 (1) : 2 - 2
[8] The US FDA has notified the cystic fibrosis (CF) community about the possible risk of cataract development in children taking ivacaftor [Kalydeco].
Reactions Weekly, 2012, 1418 (1) : 3 - 3
[9] The recent full clinical hold placed on trials of canfosfamide [Telcyta]* has been converted to a partial hold by the US FDA
Reactions Weekly, 2007, 1157 (1) : 3 - 3
[10] Harvard Pilgrim has been awarded a one-year contract to develop a pilot for the US FDA's Sentinel System.
Reactions Weekly, 2010, 1285 (1) : 3 - 3